MLchartDataset catalogue

capecitabine/methotrexate/vinorelbine regimen

Term · Oncology and biomedicine · MLC-T-ONC-012232

A regimen composed of capecitabine, methotrexate and vinorelbine that can potentially be used in the treatment of breast cancer.

Table 1. Record
IdentifierMLC-T-ONC-012232
FieldOncology and biomedicine
SynonymsXeloda/methotrexate/navelbine regimen; capecitabine-methotrexate-vinorelbine regimen; Xeloda-methotrexate-navelbine regimen; XMV regimen; capecitabine/methotrexate/vinorelbine tartrate regimen
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012232",
  "term": "capecitabine/methotrexate/vinorelbine regimen",
  "field": "Oncology and biomedicine",
  "definition": "A regimen composed of capecitabine, methotrexate and vinorelbine that can potentially be used in the treatment of breast cancer.",
  "synonyms": [
    "Xeloda/methotrexate/navelbine regimen",
    "capecitabine-methotrexate-vinorelbine regimen",
    "Xeloda-methotrexate-navelbine regimen",
    "XMV regimen",
    "capecitabine/methotrexate/vinorelbine tartrate regimen"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/capecitabine-methotrexate-vinorelbine-regimen/"
}

Record 4,107 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.